Recombinant human insulin biosimilar (Rechon Life Sciences)
重组人胰岛素生物类似药 (Rechon Life Sciences)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human insulin biosimilar (Rechon Life Sciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRechon Life Science Ab
China Registration ClassN/A
Develop Information
Active CompaniesRechon Life Science Ab
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code +[5]
Related LinksN/A